We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$809M
AUM Growth
-$221M
Cap. Flow
-$234M
Cap. Flow %
-28.88%
Top 10 Hldgs %
38.79%
Holding
5,677
New
1,365
Increased
1,774
Reduced
1,410
Closed
1,002

Sector Composition

Rank Sector Weight
1 Financials 4.61%
2 Consumer Discretionary 4.23%
3 Healthcare 3.96%
4 Technology 3.11%
5 Energy 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOIL
4226
DELISTED
IQ Global Oil Small Cap ETF
IOIL
$1K ﹤0.01%
60
+59
+5,900% +$898
TTF
4227
DELISTED
Thai Fund
TTF
$1K ﹤0.01%
100
-102
-50% -$969
IXYS
4228
DELISTED
IXYS Corp
IXYS
$1K ﹤0.01%
+68
New +$813
SWNC
4229
DELISTED
Southwestern Energy Company
SWNC
$1K ﹤0.01%
+28
New +$1.51K
XBKS
4230
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$1K ﹤0.01%
30
OCRX
4231
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1K ﹤0.01%
+263
New +$1.52K
FSBK
4232
DELISTED
First South Bancorp Inc/VA
FSBK
$1K ﹤0.01%
109
+47
+76% +$378
SCLN
4233
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$1K ﹤0.01%
100
-6,292
-98% -$50.1K
CACQ
4234
DELISTED
Caesars Acquisition Company
CACQ
$1K ﹤0.01%
100
+54
+117% +$418
UMX
4235
DELISTED
ProShares Ultra MSCI Mexico Capped IMI
UMX
$1K ﹤0.01%
38
-62
-62% -$2.02K
MACK
4236
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1K ﹤0.01%
13
-211
-94% -$18K
NVET
4237
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$1K ﹤0.01%
+155
New +$1.47K
TRR
4238
DELISTED
Trc Companies
TRR
$1K ﹤0.01%
138
-280
-67% -$2.11K
WSTL
4239
DELISTED
Westell Technologies Inc
WSTL
$1K ﹤0.01%
115
-9
-7% -$50
TROVW
4240
DELISTED
TrovaGene, Inc. Warrant
TROVW
$1K ﹤0.01%
150
+123
+456% +$467
STV
4241
DELISTED
China Digital Tv Hldgs Co Ltd
STV
$1K ﹤0.01%
325
+212
+188% +$630
ERS
4242
DELISTED
Empire Resources, Inc.
ERS
$1K ﹤0.01%
297
-258
-46% -$1.15K
KZ
4243
DELISTED
KongZhong Corporation
KZ
$1K ﹤0.01%
200
-366
-65% -$1.97K
GGE
4244
DELISTED
Guggenheim Enhncd Eqty Strtgy Fd
GGE
$1K ﹤0.01%
63
-182
-74% -$3.18K
TVIZ
4245
DELISTED
VelocityShares Daily 2x VIX Medium Term ETN
TVIZ
$1K ﹤0.01%
11
-62
-85% -$6.64K
TSL
4246
DELISTED
Trina Solar Limited
TSL
$1K ﹤0.01%
100
-5,754
-98% -$59.6K
YDKN
4247
DELISTED
Yadkin Financial Corporation
YDKN
$1K ﹤0.01%
70
-275
-80% -$5.33K
JPEP
4248
DELISTED
JP Energy Partners LP
JPEP
$1K ﹤0.01%
113
+33
+41% +$441
PRZM
4249
DELISTED
Prism Technologies Group, Inc
PRZM
$1K ﹤0.01%
229
+79
+53% +$212
TMH
4250
DELISTED
Team Health Holdings Inc
TMH
$1K ﹤0.01%
10
-110
-92% -$6.24K

Similar funds

Tower Research Capital (TRC)'s Q1 2015 Portfolio in Review

As of Q1 2015, Tower Research Capital (TRC) held 5,677 positions worth $809M, down 21% from $1.03B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Tower Research Capital (TRC) withdrew a net $234M in Q1 2015, closing 1,002 positions and reducing 1,410 holdings. Its most notable exit was iShares Core S&P Mid-Cap ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in VanEck Semiconductor ETF worth $24.6M.

  • Tower Research Capital (TRC)'s largest Q1 2015 buy was VanEck Semiconductor ETF: 889,360 shares worth $24.6M.
  • Tower Research Capital (TRC) added most to VanEck Gold Miners ETF in Q1 2015, an estimated $21.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $252M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2015, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 39% of its $809M portfolio in Q1 2015.
  • Tower Research Capital (TRC) opened 1,365 new positions and closed 1,002 in Q1 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 21% quarter-over-quarter to $809M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.